MJ Hudson advises Kindred Capital on establishment of second VC fund

MJ Hudson has advised Kindred Capital, early stage venture capital firm, on the establishment of a venture capital fund in Luxembourg which will focus on investments in a diversified selection of high-potential early stage technology start-ups in the UK and Europe. 

Investors in the fund included British Patient Capital, a subsidiary of British Business Bank which also supported Kindred Capital in respect of the launch of its first fund as well a number of institutional investors who have chosen to re-up. Kindred Capital II achieved final closing being oversubscribed with investor commitments above its target size of GBP80 million.

The MJ Hudson team worked with a number of institutional investors and had the opportunity to work with British Patient Capital which chose to continue to support the Kindred Capital team once more. MJ Hudson was the project lead, managing other service providers to first closing. The matter was led by Karma Samdup, with support from Ronan McCann, Arooj Khan and William Barrott.

MJ Hudson has previously worked with Kindred Capital on the establishment of its first fund in Luxembourg, which provides pre-seed and seed capital to companies in the UK and Europe and further invests in the best-performing companies up to Series A and Series B funding rounds. MJ Hudson also assisted with the transfer of warehoused investments to Kindred Capital’s first fund following first closing and provided advice in relation to the marketing materials prepared by Kindred Capital.

Karma Samdup, Partner, says: “We are very pleased to have assisted the Kindred team in holding the final closing of their second fund with total commitments above their GBP80 million target size. This is a fantastic achievement given the current climate. We look forward to working with the Kindred team and support them in establishing future funds.”

Leila Rastegar Zegna, Partner at Kindred Capital, adds: “The team at MJ Hudson combines a professional yet entrepreneurial approach, which was critical for our fundraising process.  Their support has been invaluable, and we particularly appreciate their ability to remain focused on the key commercial outcomes while trying to reduce complexity. We look forward to continuing to work with them over the years to come.”